Atlas Trials

High Grade B-Cell Lymphoma, Not Otherwise Specified

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Grade B-Cell Lymphoma, Not Otherwise Specified

RecordFirmDate
Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma (NCT05202782)Northwestern University2022-03-21
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma (NCT04799275)National Cancer Institute (NCI)2021-05-20
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma (NCT05097443)Shandong Provincial Hospital2021-04-15
Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma (NCT05164770)Shandong Provincial Hospital2021-03-01
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma (NCT04231877)University of Washington2020-10-27
Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT04285268)Rutgers, The State University of New Jersey2020-05-06
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas (NCT03984448)National Cancer Institute (NCI)2019-10-22
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672)National Cancer Institute (NCI)2018-12-21
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia (NCT02153580)City of Hope Medical Center2014-09-24
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia (NCT01371630)M.D. Anderson Cancer Center2011-08-26

Track High Grade B-Cell Lymphoma, Not Otherwise Specified automatically

Every clearance here is in the API, with alerts when new ones post.